Search results
Pfizer stock price analysis: how PFE became a fallen angel | Invezz
Invezz· 1 day agoPfizer (NYSE: PFE) stock price has crashed hard in the past few years as demand for Covid-19...
Pfizer (PFE) Exceeds Market Returns: Some Facts to Consider
Zacks via Yahoo Finance· 1 day agoWe can also see that PFE currently has a PEG ratio of 1.06. The PEG ratio bears resemblance...factor...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 2 days agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
7,403 Shares in Pfizer Inc. (NYSE:PFE) Bought by Gerber LLC
ETF DAILY NEWS· 3 days agoGerber LLC bought a new position in Pfizer Inc. (NYSE:PFE – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund bought 7,403 shares of the biopharmaceutical ...
Pfizer (PFE) Phase III DMD Gene Therapy Study Misses Goal
Zacks via Yahoo Finance· 6 days agoPfizer's (PFE) phase III study, CIFFREO, fails to show improvement in motor function in ambulatory...
Best Blue Chip Stocks To Buy in June 2024
GoBankingRates via AOL· 2 days agoBlue chip stocks are among the safest and most secure buys that investors can add to their portfolios. Here are some of the best blue chip stocks to...
Indexes Close Near Session Highs, But Small Caps Struggle; Tesla Pares Gains (Live Coverage)
Investor's Business Daily· 6 days agoDow Jones fell slightly but other indexes rose to record highs after inflation data. Tesla soared as...
Merck's (MRK) 21-Valent Pneumococcal Jab Gets FDA Approval
Zacks via Yahoo Finance· 1 day agoMerck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive/V116, becomes the first PCV...
Sarepta Jumps After Rival Gene Therapy From Pfizer Flops
Investor's Business Daily· 6 days agoThe news gives Sarepta Therapeutics (SRPT) an edge heading to June 21, when the Food and Drug Administration will decide whether to fully approve Elevidys for patients with the muscle-wasting ...
Moderna stock is lone omen of bird flu pandemic
Reuters· 2 days agoThe recent rise of Moderna’s stock tells a grim tale. The $56 billion company which pioneered a Covid vaccine has seen its market value rise 40% since...
